Research and innovation news

A team at The University of Manchester have found that the standard treatment for asthma - oral steroids - was associated with increased levels of the treatable mould Aspergillus in the lung.

MAHSC Inflammation & Repair and Cardiovascular Domains is funding the programme fees for two project teams on Haelo’s 2018-19 Improvement Science for Leaders programme

An international team of scientists and doctors has identified a family of five new genetic diseases which are likely to affect more than 1 in 5000 children.

We'd like to say a massive thank you to everyone who participated in, delivered or supported research at Manchester University NHS Foundation Trust during 2017. 

At the start of 2017 teams were challenged to pursue as many first patients recruited to commercially sponsored trials as they could, whether first global, European or UK. Find out how well they did!

The World Health Organization (WHO) is recommending early use of tranexamic acid to treat bleeding post childbirth after fresh analysis of the WOMAN trial was published in The Lancet.

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human. It successfully lowered the level of the harmful huntingtin protein the nervous system.

An international team of scientists and doctors has identified a new disease that results in low levels of a common protein found inside our cells.